Roth MKM Reinstates Buy on Journey Medical, Announces $11 Price Target
Journey Medical Corp. +4.17% Pre
Journey Medical Corp. DERM | 6.00 6.00 | +4.17% 0.00% Pre |
Roth MKM analyst Jason Wittes reinstates Journey Medical (NASDAQ:
DERM) with a Buy and announces $11 price target.